Previous close | 82.76 |
Open | 83.00 |
Bid | 82.03 x 1200 |
Ask | 84.00 x 800 |
Day's range | 82.28 - 83.06 |
52-week range | 68.84 - 91.00 |
Volume | |
Avg. volume | 6,220,238 |
Market cap | 109.997B |
Beta (5Y monthly) | 0.80 |
PE ratio (TTM) | 26.30 |
EPS (TTM) | 3.15 |
Earnings date | 23 May 2024 |
Forward dividend & yield | 2.76 (3.33%) |
Ex-dividend date | 21 Mar 2024 |
1y target est | 94.00 |
Medtronic's (MDT) rapid cadence of new product approvals is a strong foundation for future growth. However, the company also navigates some macroeconomic challenges.
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and CompaniesLOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market, today announced that Medtronic plc (NYSE: MDT), a global leader in healthcare technology, has been selected as winner of the “Best New Mo
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2024 on Thursday, May 23, 2024. A news release will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at https://news.medtronic.com. The news release will include summary financial information for the company's fourth quarter and full fiscal year 2024, which ended on Friday, April 26, 2024.